TB (.xlsx)
Download original .xlsx file from GitHub
parameters
parameter_name |
value |
lower |
upper |
notes |
|
---|---|---|---|---|---|
0 |
scaling_factor_WHO |
1.60303 |
|||
1 |
prop_mdr2010 |
0.0186 |
|||
2 |
monthly_prob_relapse_tx_complete |
0.0027 |
0.0014 |
0.00405 |
|
3 |
monthly_prob_relapse_tx_incomplete |
0.0116 |
0.0058 |
0.0174 |
|
4 |
monthly_prob_relapse_2yrs |
0.0001 |
5e-05 |
0.0015 |
|
5 |
rr_relapse_hiv |
4.7 |
|||
6 |
rr_relapse_diabetes |
1.86 |
Huangfu et al 2019 |
||
7 |
duration_active_disease_years |
3 |
|||
8 |
prop_smear_positive |
0.62 |
0.42 |
0.8 |
|
9 |
prop_smear_positive_hiv |
0.35 |
0.19 |
0.54 |
|
10 |
death_rate_child0_4_treated |
0.05 |
|||
11 |
death_rate_child5_14_treated |
0.06 |
|||
12 |
death_rate_adult_treated |
0.107 |
changed from 0.086 |
||
13 |
death_rate_smear_pos_untreated |
0.7 |
|||
14 |
death_rate_smear_neg_untreated |
0.2 |
|||
15 |
rr_death_diabetes |
1.51 |
Huangfu et al 2019 |
||
16 |
rr_tb_child |
0.1 |
assumed |
||
17 |
rr_tb_bcg |
0.42 |
|||
18 |
rr_tb_hiv |
5 |
assumed |
20.6getahun2010 |
|
19 |
rr_tb_aids |
26 |
assumed |
26williams_pnas |
|
20 |
rr_tb_art_adult |
0.35 |
|||
21 |
rr_tb_art_child |
0.3 |
|||
22 |
rr_tb_obese |
0.4 |
|||
23 |
rr_tb_diabetes |
3 |
|||
24 |
rr_tb_alcohol |
2.9 |
|||
25 |
rr_tb_smoking |
1.3 |
|||
26 |
rr_ipt_adult |
0.4 |
|||
27 |
rr_ipt_child |
0.55 |
|||
28 |
rr_ipt_adult_hiv |
0.68 |
|||
29 |
rr_ipt_child_hiv |
0.31 |
|||
30 |
rr_ipt_art_child |
0.76 |
|||
31 |
rr_ipt_art_adult |
0.63 |
|||
32 |
sens_xpert_smear_negative |
0.68 |
|||
33 |
sens_xpert_smear_positive |
0.98 |
|||
34 |
spec_xpert_smear_negative |
0.99 |
|||
35 |
spec_xpert_smear_positive |
0.99 |
|||
36 |
sens_sputum_smear_positive |
1 |
|||
37 |
spec_sputum_smear_positive |
1 |
|||
38 |
sens_clinical |
0.209 |
0.12 |
0.33 |
|
39 |
spec_clinical |
0.953 |
0.92 |
0.97 |
|
40 |
sens_xray_smear_negative |
0.8 |
|||
41 |
sens_xray_smear_positive |
0.91 |
|||
42 |
spec_xray_smear_negative |
0.67 |
|||
43 |
spec_xray_smear_positive |
0.67 |
|||
44 |
prob_tx_success_ds |
0.837 |
|||
45 |
prob_tx_success_mdr |
0.597 |
|||
46 |
prob_tx_success_0_4 |
0.94 |
|||
47 |
prob_tx_success_5_14 |
0.92 |
|||
48 |
rate_testing_general_pop |
0.025 |
|||
49 |
ds_treatment_length |
6 |
|||
50 |
ds_retreatment_length |
8 |
|||
51 |
mdr_treatment_length |
24 |
|||
52 |
prob_retained_ipt_6_months |
0.9 |
|||
53 |
age_eligibility_for_ipt |
5 |
|||
54 |
ipt_start_date |
2014 |
|||
55 |
first_line_test |
sputum |
|||
56 |
second_line_test |
xpert |
|||
57 |
tb_healthseekingbehaviour_cap |
5 |
|||
58 |
data_end |
2022 |
|||
59 |
length_of_inpatient_stay_if_terminal |
[5,10] |
|||
60 |
type_of_scaleup |
none |
|||
61 |
scaleup_start_year |
2025 |
scaleup_parameters
parameter |
target_value |
min_value |
max_value |
|
---|---|---|---|---|
0 |
tb_treatment_coverage |
90 |
0 |
100 |
1 |
tb_prob_tx_success_ds |
0.9 |
0 |
1 |
2 |
tb_prob_tx_success_mdr |
0.9 |
0 |
1 |
3 |
tb_prob_tx_success_0_4 |
0.9 |
0 |
1 |
4 |
tb_prob_tx_success_5_14 |
0.9 |
0 |
1 |
5 |
first_line_test |
xpert |
sputum |
xpert |
6 |
second_line_test |
sputum |
sputum |
xpert |
7 |
ipt_coverage_plhiv |
0.9 |
0 |
1 |
8 |
ipt_coverage_paediatric |
90 |
0 |
100 |
calibrated_transmission_rates
draw |
hiv |
tb |
deviance |
|
---|---|---|---|---|
0 |
1 |
0.125176 |
16.7101 |
0.814946 |
1 |
12 |
0.121988 |
18.0221 |
0.83383 |
2 |
0 |
0.10922 |
15.8241 |
0.862322 |
3 |
9 |
0.115698 |
19.2184 |
0.92932 |
4 |
16 |
0.13272 |
15.4037 |
0.96256 |
IPTdistricts
district_name |
region |
|
---|---|---|
0 |
Lilongwe City |
central |
1 |
Blantyre |
southern |
2 |
Mangochi |
southern |
3 |
Machinga |
southern |
4 |
Chikwawa |
southern |
5 |
Mzimba |
northern |
6 |
Thyolo |
southern |
7 |
Mulanje |
southern |
8 |
Nsanje |
southern |
9 |
Chiradzulu |
southern |
all_districts
district_name |
|
---|---|
0 |
Balaka |
1 |
Blantyre |
2 |
Blantyre City |
3 |
Chikwawa |
4 |
Chiradzulu |
5 |
Chitipa |
6 |
Dedza |
7 |
Dowa |
8 |
Karonga |
9 |
Kasungu |
10 |
Likoma |
11 |
Lilongwe |
12 |
Lilongwe City |
13 |
Machinga |
14 |
Mangochi |
15 |
Mchinji |
16 |
Mulanje |
17 |
Mwanza |
18 |
Mzimba |
19 |
Mzuzu City |
20 |
Neno |
21 |
Nkhata Bay |
22 |
Nkhotakota |
23 |
Nsanje |
24 |
Ntcheu |
25 |
Ntchisi |
26 |
Phalombe |
27 |
Rumphi |
28 |
Salima |
29 |
Thyolo |
30 |
Zomba |
31 |
Zomba City |
ipt_coverage
year |
coverage_plhiv |
source |
coverage_paediatric |
source2 |
|
---|---|---|---|---|---|
0 |
2010 |
0 |
not_implemented |
0 |
|
1 |
2011 |
0 |
not_implemented |
0 |
|
2 |
2012 |
0 |
not_implemented |
0 |
|
3 |
2013 |
0 |
not_implemented |
0 |
|
4 |
2014 |
0 |
not_implemented |
35 |
NTP2019 |
5 |
2015 |
0 |
not_implemented |
42 |
NTP2019 |
6 |
2016 |
0 |
not_implemented |
51 |
NTP2019 |
7 |
2017 |
0 |
not_implemented |
61 |
NTP2019 |
8 |
2018 |
0.31 |
MoH_quart_repQ1 |
57 |
NTP2019 |
9 |
2019 |
0.3 |
MoH_quart_repQ2 |
57 |
NTP2020 |
10 |
2020 |
0.11 |
MoH_quart_repQ3 |
48 |
NTP2020 |
11 |
2021 |
0.3 |
no_data |
41 |
NTP2021 |
12 |
2022 |
0.3 |
no_data |
57 |
|
13 |
2023 |
0.3 |
no_data |
57 |
|
14 |
2024 |
0.3 |
no_data |
57 |
|
15 |
2025 |
0.3 |
no_data |
57 |
|
16 |
2026 |
0.3 |
no_data |
57 |
|
17 |
2027 |
0.3 |
no_data |
57 |
|
18 |
2028 |
0.3 |
no_data |
57 |
|
19 |
2029 |
0.3 |
no_data |
57 |
|
20 |
2030 |
0.3 |
no_data |
57 |
|
21 |
2031 |
0.3 |
no_data |
57 |
|
22 |
2032 |
0.3 |
no_data |
57 |
|
23 |
2033 |
0.3 |
no_data |
57 |
|
24 |
2034 |
0.3 |
no_data |
57 |
|
25 |
2035 |
0.3 |
no_data |
57 |
|
26 |
2036 |
0.3 |
no_data |
57 |
|
27 |
2037 |
0.3 |
no_data |
57 |
|
28 |
2038 |
0.3 |
no_data |
57 |
|
29 |
2039 |
0.3 |
no_data |
57 |
|
30 |
2040 |
0.3 |
no_data |
57 |
|
31 |
2041 |
0.3 |
no_data |
57 |
|
32 |
2042 |
0.3 |
no_data |
57 |
|
33 |
2043 |
0.3 |
no_data |
57 |
|
34 |
2044 |
0.3 |
no_data |
57 |
|
35 |
2045 |
0.3 |
no_data |
57 |
|
36 |
2046 |
0.3 |
no_data |
57 |
|
37 |
2047 |
0.3 |
no_data |
57 |
|
38 |
2048 |
0.3 |
no_data |
57 |
|
39 |
2049 |
0.3 |
no_data |
57 |
|
40 |
2050 |
0.3 |
no_data |
57 |
testing_rates
year |
testing_rate_active_cases |
treatment_coverage |
source |
|
---|---|---|---|---|
0 |
2010 |
45 |
45 |
assumed |
1 |
2011 |
45 |
45 |
assumed |
2 |
2012 |
47 |
47 |
who_reports_treatment_coverage |
3 |
2013 |
44 |
44 |
who_reports_treatment_coverage |
4 |
2014 |
45 |
45 |
who_reports_treatment_coverage |
5 |
2015 |
50 |
50 |
who_reports_treatment_coverage |
6 |
2016 |
58 |
58 |
who_reports_treatment_coverage |
7 |
2017 |
71 |
71 |
who_reports_treatment_coverage |
8 |
2018 |
75 |
75 |
assumed |
9 |
2019 |
75 |
75 |
assumed |
10 |
2020 |
75 |
75 |
assumed |
11 |
2021 |
75 |
75 |
assumed |
12 |
2022 |
75 |
75 |
assumed |
13 |
2023 |
75 |
75 |
assumed |
14 |
2024 |
75 |
75 |
assumed |
15 |
2025 |
75 |
75 |
assumed |
16 |
2026 |
75 |
75 |
assumed |
17 |
2027 |
75 |
75 |
assumed |
18 |
2028 |
75 |
75 |
assumed |
19 |
2029 |
75 |
75 |
assumed |
20 |
2030 |
75 |
75 |
assumed |
21 |
2031 |
75 |
75 |
assumed |
22 |
2032 |
75 |
75 |
assumed |
23 |
2033 |
75 |
75 |
assumed |
24 |
2034 |
75 |
75 |
assumed |
25 |
2035 |
75 |
75 |
assumed |
26 |
2036 |
75 |
75 |
assumed |
27 |
2037 |
75 |
75 |
assumed |
28 |
2038 |
75 |
75 |
assumed |
29 |
2039 |
75 |
75 |
assumed |
30 |
2040 |
75 |
75 |
assumed |
31 |
2041 |
75 |
75 |
assumed |
32 |
2042 |
75 |
75 |
assumed |
33 |
2043 |
75 |
75 |
assumed |
34 |
2044 |
75 |
75 |
assumed |
35 |
2045 |
75 |
75 |
assumed |
36 |
2046 |
75 |
75 |
assumed |
37 |
2047 |
75 |
75 |
assumed |
38 |
2048 |
75 |
75 |
assumed |
39 |
2049 |
75 |
75 |
assumed |
40 |
2050 |
75 |
75 |
assumed |
pulm_tb
age |
hiv |
prob_pulm |
|
---|---|---|---|
0 |
0 |
False |
0.7 |
1 |
1 |
False |
0.74 |
2 |
2 |
False |
0.91 |
3 |
3 |
False |
0.91 |
4 |
4 |
False |
0.91 |
5 |
5 |
False |
0.89 |
6 |
6 |
False |
0.89 |
7 |
7 |
False |
0.89 |
8 |
8 |
False |
0.89 |
9 |
9 |
False |
0.89 |
10 |
10 |
False |
0.99 |
11 |
11 |
False |
0.99 |
12 |
12 |
False |
0.99 |
13 |
13 |
False |
0.99 |
14 |
14 |
False |
0.99 |
15 |
15 |
False |
0.8 |
16 |
16 |
False |
0.8 |
17 |
17 |
False |
0.8 |
18 |
18 |
False |
0.8 |
19 |
19 |
False |
0.8 |
20 |
20 |
False |
0.8 |
21 |
21 |
False |
0.8 |
22 |
22 |
False |
0.8 |
23 |
23 |
False |
0.8 |
24 |
24 |
False |
0.8 |
25 |
25 |
False |
0.8 |
26 |
26 |
False |
0.8 |
27 |
27 |
False |
0.8 |
28 |
28 |
False |
0.8 |
29 |
29 |
False |
0.8 |
30 |
30 |
False |
0.8 |
31 |
31 |
False |
0.8 |
32 |
32 |
False |
0.8 |
33 |
33 |
False |
0.8 |
34 |
34 |
False |
0.8 |
35 |
35 |
False |
0.8 |
36 |
36 |
False |
0.8 |
37 |
37 |
False |
0.8 |
38 |
38 |
False |
0.8 |
39 |
39 |
False |
0.8 |
40 |
40 |
False |
0.8 |
41 |
41 |
False |
0.8 |
42 |
42 |
False |
0.8 |
43 |
43 |
False |
0.8 |
44 |
44 |
False |
0.8 |
45 |
45 |
False |
0.8 |
46 |
46 |
False |
0.8 |
47 |
47 |
False |
0.8 |
48 |
48 |
False |
0.8 |
49 |
49 |
False |
0.8 |
50 |
50 |
False |
0.8 |
51 |
51 |
False |
0.8 |
52 |
52 |
False |
0.8 |
53 |
53 |
False |
0.8 |
54 |
54 |
False |
0.8 |
55 |
55 |
False |
0.8 |
56 |
56 |
False |
0.8 |
57 |
57 |
False |
0.8 |
58 |
58 |
False |
0.8 |
59 |
59 |
False |
0.8 |
60 |
60 |
False |
0.8 |
61 |
61 |
False |
0.8 |
62 |
62 |
False |
0.8 |
63 |
63 |
False |
0.8 |
64 |
64 |
False |
0.8 |
65 |
65 |
False |
0.8 |
66 |
66 |
False |
0.8 |
67 |
67 |
False |
0.8 |
68 |
68 |
False |
0.8 |
69 |
69 |
False |
0.8 |
70 |
70 |
False |
0.8 |
71 |
71 |
False |
0.8 |
72 |
72 |
False |
0.8 |
73 |
73 |
False |
0.8 |
74 |
74 |
False |
0.8 |
75 |
75 |
False |
0.8 |
76 |
76 |
False |
0.8 |
77 |
77 |
False |
0.8 |
78 |
78 |
False |
0.8 |
79 |
79 |
False |
0.8 |
80 |
80 |
False |
0.8 |
81 |
81 |
False |
0.8 |
82 |
82 |
False |
0.8 |
83 |
83 |
False |
0.8 |
84 |
84 |
False |
0.8 |
85 |
85 |
False |
0.8 |
86 |
86 |
False |
0.8 |
87 |
87 |
False |
0.8 |
88 |
88 |
False |
0.8 |
89 |
89 |
False |
0.8 |
90 |
90 |
False |
0.8 |
91 |
91 |
False |
0.8 |
92 |
92 |
False |
0.8 |
93 |
93 |
False |
0.8 |
94 |
94 |
False |
0.8 |
95 |
95 |
False |
0.8 |
96 |
96 |
False |
0.8 |
97 |
97 |
False |
0.8 |
98 |
98 |
False |
0.8 |
99 |
99 |
False |
0.8 |
100 |
100 |
False |
0.8 |
101 |
0 |
True |
0.5 |
102 |
1 |
True |
0.5 |
103 |
2 |
True |
0.5 |
104 |
3 |
True |
0.5 |
105 |
4 |
True |
0.5 |
106 |
5 |
True |
0.5 |
107 |
6 |
True |
0.5 |
108 |
7 |
True |
0.5 |
109 |
8 |
True |
0.5 |
110 |
9 |
True |
0.5 |
111 |
10 |
True |
0.5 |
112 |
11 |
True |
0.5 |
113 |
12 |
True |
0.5 |
114 |
13 |
True |
0.5 |
115 |
14 |
True |
0.5 |
116 |
15 |
True |
0.5 |
117 |
16 |
True |
0.5 |
118 |
17 |
True |
0.5 |
119 |
18 |
True |
0.5 |
120 |
19 |
True |
0.5 |
121 |
20 |
True |
0.5 |
122 |
21 |
True |
0.5 |
123 |
22 |
True |
0.5 |
124 |
23 |
True |
0.5 |
125 |
24 |
True |
0.5 |
126 |
25 |
True |
0.5 |
127 |
26 |
True |
0.5 |
128 |
27 |
True |
0.5 |
129 |
28 |
True |
0.5 |
130 |
29 |
True |
0.5 |
131 |
30 |
True |
0.5 |
132 |
31 |
True |
0.5 |
133 |
32 |
True |
0.5 |
134 |
33 |
True |
0.5 |
135 |
34 |
True |
0.5 |
136 |
35 |
True |
0.5 |
137 |
36 |
True |
0.5 |
138 |
37 |
True |
0.5 |
139 |
38 |
True |
0.5 |
140 |
39 |
True |
0.5 |
141 |
40 |
True |
0.5 |
142 |
41 |
True |
0.5 |
143 |
42 |
True |
0.5 |
144 |
43 |
True |
0.5 |
145 |
44 |
True |
0.5 |
146 |
45 |
True |
0.5 |
147 |
46 |
True |
0.5 |
148 |
47 |
True |
0.5 |
149 |
48 |
True |
0.5 |
150 |
49 |
True |
0.5 |
151 |
50 |
True |
0.5 |
152 |
51 |
True |
0.5 |
153 |
52 |
True |
0.5 |
154 |
53 |
True |
0.5 |
155 |
54 |
True |
0.5 |
156 |
55 |
True |
0.5 |
157 |
56 |
True |
0.5 |
158 |
57 |
True |
0.5 |
159 |
58 |
True |
0.5 |
160 |
59 |
True |
0.5 |
161 |
60 |
True |
0.5 |
162 |
61 |
True |
0.5 |
163 |
62 |
True |
0.5 |
164 |
63 |
True |
0.5 |
165 |
64 |
True |
0.5 |
166 |
65 |
True |
0.5 |
167 |
66 |
True |
0.5 |
168 |
67 |
True |
0.5 |
169 |
68 |
True |
0.5 |
170 |
69 |
True |
0.5 |
171 |
70 |
True |
0.5 |
172 |
71 |
True |
0.5 |
173 |
72 |
True |
0.5 |
174 |
73 |
True |
0.5 |
175 |
74 |
True |
0.5 |
176 |
75 |
True |
0.5 |
177 |
76 |
True |
0.5 |
178 |
77 |
True |
0.5 |
179 |
78 |
True |
0.5 |
180 |
79 |
True |
0.5 |
181 |
80 |
True |
0.5 |
182 |
81 |
True |
0.5 |
183 |
82 |
True |
0.5 |
184 |
83 |
True |
0.5 |
185 |
84 |
True |
0.5 |
186 |
85 |
True |
0.5 |
187 |
86 |
True |
0.5 |
188 |
87 |
True |
0.5 |
189 |
88 |
True |
0.5 |
190 |
89 |
True |
0.5 |
191 |
90 |
True |
0.5 |
192 |
91 |
True |
0.5 |
193 |
92 |
True |
0.5 |
194 |
93 |
True |
0.5 |
195 |
94 |
True |
0.5 |
196 |
95 |
True |
0.5 |
197 |
96 |
True |
0.5 |
198 |
97 |
True |
0.5 |
199 |
98 |
True |
0.5 |
200 |
99 |
True |
0.5 |
201 |
100 |
True |
0.5 |
additional_params
prop_pulm |
0.8 |
|
---|---|---|
0 |
prop_pulm_hiv |
0.5 |
1 |
prop_pulm_1yr |
0.7 |
2 |
prop_pulm_1_2yr |
0.74 |
3 |
prop_pulm_2_5yr |
0.91 |
4 |
prop_pulm_5_10yr |
0.89 |
5 |
prop_pulm_10yr |
0.99 |
6 |
rr_tbm_bcg |
0.27 |
7 |
rr_miliary_bcg |
0.23 |
cases2010district
district |
region |
cases_2010 |
pop |
proportion_active |
all_cases |
whole_pop |
general_prob |
|
---|---|---|---|---|---|---|---|---|
0 |
Balaka |
Southern |
1563 |
438379 |
0.00356541 |
50000 |
17563749 |
0.00284677 |
1 |
Blantyre |
Southern |
1563 |
451220 |
0.00346394 |
50000 |
17563749 |
0.00284677 |
2 |
Blantyre City |
Southern |
1563 |
800264 |
0.00195311 |
50000 |
17563749 |
0.00284677 |
3 |
Chikwawa |
Southern |
1563 |
564684 |
0.00276792 |
50000 |
17563749 |
0.00284677 |
4 |
Chiradzulu |
Southern |
1563 |
356875 |
0.00437968 |
50000 |
17563749 |
0.00284677 |
5 |
Chitipa |
Northern |
1563 |
234927 |
0.00665313 |
50000 |
17563749 |
0.00284677 |
6 |
Dedza |
Central |
1563 |
830512 |
0.00188197 |
50000 |
17563749 |
0.00284677 |
7 |
Dowa |
Central |
1563 |
772569 |
0.00202312 |
50000 |
17563749 |
0.00284677 |
8 |
Karonga |
Northern |
1563 |
365028 |
0.00428186 |
50000 |
17563749 |
0.00284677 |
9 |
Kasungu |
Central |
1563 |
842953 |
0.0018542 |
50000 |
17563749 |
0.00284677 |
10 |
Likoma |
Northern |
1563 |
14527 |
0.107593 |
50000 |
17563749 |
0.00284677 |
11 |
Lilongwe |
Central |
1563 |
1637583 |
0.000954455 |
50000 |
17563749 |
0.00284677 |
12 |
Lilongwe City |
Central |
1563 |
989318 |
0.00157988 |
50000 |
17563749 |
0.00284677 |
13 |
Machinga |
Southern |
1563 |
735438 |
0.00212526 |
50000 |
17563749 |
0.00284677 |
14 |
Mangochi |
Southern |
1563 |
1148611 |
0.00136077 |
50000 |
17563749 |
0.00284677 |
15 |
Mchinji |
Central |
1563 |
602305 |
0.00259503 |
50000 |
17563749 |
0.00284677 |
16 |
Mulanje |
Southern |
1563 |
684107 |
0.00228473 |
50000 |
17563749 |
0.00284677 |
17 |
Mwanza |
Southern |
1563 |
130949 |
0.0119359 |
50000 |
17563749 |
0.00284677 |
18 |
Mzimba |
Northern |
1563 |
936250 |
0.00166943 |
50000 |
17563749 |
0.00284677 |
19 |
Mzuzu City |
Northern |
1563 |
221272 |
0.0070637 |
50000 |
17563749 |
0.00284677 |
20 |
Neno |
Southern |
1563 |
138291 |
0.0113023 |
50000 |
17563749 |
0.00284677 |
21 |
Nkhata Bay |
Northern |
1563 |
285795 |
0.00546896 |
50000 |
17563749 |
0.00284677 |
22 |
Nkhotakota |
Central |
1563 |
395897 |
0.003948 |
50000 |
17563749 |
0.00284677 |
23 |
Nsanje |
Southern |
1563 |
299168 |
0.00522449 |
50000 |
17563749 |
0.00284677 |
24 |
Ntcheu |
Central |
1563 |
659608 |
0.00236959 |
50000 |
17563749 |
0.00284677 |
25 |
Ntchisi |
Central |
1563 |
317069 |
0.00492953 |
50000 |
17563749 |
0.00284677 |
26 |
Phalombe |
Southern |
1563 |
429450 |
0.00363954 |
50000 |
17563749 |
0.00284677 |
27 |
Rumphi |
Northern |
1563 |
229161 |
0.00682053 |
50000 |
17563749 |
0.00284677 |
28 |
Salima |
Central |
1563 |
478346 |
0.00326751 |
50000 |
17563749 |
0.00284677 |
29 |
Thyolo |
Southern |
1563 |
721456 |
0.00216645 |
50000 |
17563749 |
0.00284677 |
30 |
Zomba |
Southern |
1563 |
746724 |
0.00209314 |
50000 |
17563749 |
0.00284677 |
31 |
Zomba City |
Southern |
1563 |
105013 |
0.0148839 |
50000 |
17563749 |
0.00284677 |
details_rates
parameter |
value1 |
value2 |
value3 |
value4 |
monthly_rate |
monthly_probability |
Unnamed: 7 |
source |
Unnamed: 9 |
|
---|---|---|---|---|---|---|---|---|---|---|
0 |
prop_fast_progressor |
0.14 |
vynnycky |
|||||||
1 |
transmission_rate |
4.9 |
juan |
|||||||
2 |
annual_progression_to_active_rate |
0.05 |
0.004166666666666667 |
0.004157998154890041 |
horsburgh |
|||||
3 |
rr_tb_with_hiv_stages |
3.44 |
6.76 |
13.28 |
26.06 |
williams_pnas2010 |
||||
4 |
rr_tb_art |
0.35 |
suthar_juan |
|||||||
5 |
rr_tb_ipt |
0.63 |
rangaka_juan |
|||||||
6 |
rr_tb_malnourished |
2.1 |
lonroth2010_dcp3 |
|||||||
7 |
rr_tb_diabetes1 |
3 |
joen2008_dcp3 |
|||||||
8 |
rr_tb_alcohol |
2.9 |
lonroth2008_dcp3 |
|||||||
9 |
rr_tb_smoking |
2.6 |
lin2007_dcp3 |
|||||||
10 |
rr_tb_pollution |
1.5 |
lin2007_dcp3 |
|||||||
11 |
rel_infectiousness_hiv |
0.68 |
juan |
|||||||
12 |
annual_rate_self_cure_old_value |
0.2 |
0.016666666666666666 |
0.01652854617838251 |
dye_1998_lancet |
|||||
13 |
annual_rate_self_cure |
0.33 |
Tiemersma |
|||||||
14 |
tb_mortality_rate |
0.15 |
0.012499999999999999 |
0.012422199506118559 |
juan |
|||||
15 |
tb_mortality_hiv_rate |
0.84 |
0.06999999999999999 |
0.06760618009405173 |
juan |
|||||
16 |
prop_mdr2010 |
0.0186 |
abouyannis |
|||||||
17 |
prop_mdr_new |
0.075 |
who2017reports |
|||||||
18 |
prop_mdr_retreated |
0.064 |
who2017reports |
|||||||
19 |
rate_relapse_tx_complete |
0.032 |
0.0026666666666666666 |
0.002663114269499056 |
juan_tableparams |
|||||
20 |
rate_relapse_tx_incomplete |
0.14 |
0.011666666666666667 |
0.011598875001476161 |
juan_tableparams |
|||||
21 |
rate_relapse_2yrs |
0.0015 |
0.000125 |
0.00012499218782546784 |
juan_tableparams |
followup
ds_sputum |
ds_clinical_monitor |
ds_retreatment_sputum |
ds_retreatment_clinical |
mdr_sputum |
mdr_clinical_monitor |
shine_sputum |
shine_clinical_monitor |
|
---|---|---|---|---|---|---|---|---|
0 |
2 |
1 |
3 |
1 |
2 |
1 |
2 |
1 |
1 |
5 |
2 |
5 |
2 |
5 |
2 |
4 |
2 |
2 |
6 |
3 |
8 |
3 |
6 |
3 |
3 |
|
3 |
4 |
4 |
8 |
4 |
4 |
|||
4 |
5 |
5 |
10 |
5 |
||||
5 |
6 |
6 |
12 |
6 |
||||
6 |
7 |
14 |
7 |
|||||
7 |
8 |
16 |
8 |
|||||
8 |
18 |
9 |
||||||
9 |
20 |
10 |
||||||
10 |
22 |
11 |
||||||
11 |
24 |
12 |
||||||
12 |
13 |
|||||||
13 |
14 |
|||||||
14 |
15 |
|||||||
15 |
16 |
|||||||
16 |
17 |
|||||||
17 |
18 |
|||||||
18 |
19 |
|||||||
19 |
20 |
|||||||
20 |
21 |
|||||||
21 |
22 |
|||||||
22 |
23 |
|||||||
23 |
24 |
latent_TB2014_summary
Age_group |
latent_TB_prev |
lower_estimate |
upper_estimate |
population_size2016 |
proportion_latent_TB |
proportion_latent_TB_lower |
proportion_latent_TB_upper |
|
---|---|---|---|---|---|---|---|---|
0 |
0_14 |
525000 |
476000 |
567000 |
7847053 |
0.0669041 |
0.0606597151822474 |
0.07225642543767705 |
1 |
15_80 |
2645000 |
9726553 |
0.271936 |
||||
2 |
0_80 |
3170000 |
2850000 |
3720000 |
17573606 |
0.180384 |
0.16217502543302723 |
0.2116810858283724 |
WHO_activeTB2023
year |
bcg_coverage |
incidence_per_100k |
incidence_per_100k_low |
incidence_per_100k_high |
percentage_tb_with_hiv |
percentage_tb_with_hiv_low |
percentage_tb_with_hiv_high |
mortality_tb_excl_hiv_per_100k |
mortality_tb_excl_hiv_per_100k_low |
mortality_tb_excl_hiv_per_100k_high |
mortality_tb_hiv_per_100k |
mortality_tb_hiv_per_100k_low |
mortality_tb_hiv_per_100k_high |
total_mortality_tb_per_100k |
total_mortality_tb_per_100k_low |
total_mortality_tb_per_100k_high |
num_deaths_tb_nonHiv |
num_deaths_tb_nonHiv_low |
num_deaths_tb_nonHiv_high |
prevalence_all_ages |
prevalence_all_ages_low |
prevalence_all_ages_high |
case_detection_rate |
case_detection_rate_lower |
case_detection_rate_upper |
TB_program_tx_coverage |
case_fatality_rate |
case_fatality_rate_low |
case_fatality_rate_high |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 |
2000 |
83 |
386 |
43 |
1100 |
79 |
65 |
91 |
20 |
6.1 |
43 |
116 |
60 |
191 |
137 |
77 |
213 |
2300 |
680 |
4900 |
0.003955636395089666 |
0.0022854788060518074 |
0.0059774061081354956 |
54 |
19 |
490 |
0.54 |
0.05 |
0.97 |
|
1 |
2001 |
93 |
395 |
40 |
1140 |
77 |
53 |
94 |
18 |
3.9 |
43 |
116 |
59 |
192 |
134 |
73 |
213 |
2100 |
450 |
4900 |
0.003933014605249737 |
0.0023085085726465846 |
0.005985022225380034 |
57 |
20 |
560 |
0.53 |
0.05 |
0.97 |
|
2 |
2002 |
78 |
401 |
39 |
1170 |
71 |
53 |
86 |
29 |
9.5 |
58 |
113 |
56 |
190 |
142 |
79 |
223 |
3400 |
1100 |
6900 |
0.003995434882693616 |
0.002413908574960726 |
0.00590991409731764 |
52 |
18 |
540 |
0.56 |
0.04 |
0.98 |
|
3 |
2003 |
91 |
403 |
38 |
1190 |
68 |
49 |
84 |
27 |
9.3 |
55 |
100 |
49 |
168 |
127 |
71 |
199 |
3300 |
1100 |
6600 |
0.003971892940138629 |
0.0024317711878399768 |
0.005917309890410611 |
58 |
20 |
610 |
0.5 |
0.06 |
0.94 |
|
4 |
2004 |
97 |
402 |
39 |
1180 |
67 |
47 |
83 |
30 |
10 |
60 |
105 |
51 |
178 |
135 |
75 |
212 |
3700 |
1300 |
7500 |
0.003944450150748996 |
0.0024455590934643772 |
0.005837786223108514 |
54 |
18 |
570 |
0.53 |
0.05 |
0.97 |
|
5 |
2005 |
99 |
398 |
40 |
1160 |
67 |
47 |
84 |
31 |
10 |
63 |
111 |
54 |
190 |
143 |
79 |
225 |
4000 |
1300 |
8000 |
0.003987818441681721 |
0.0024540421179579824 |
0.005828350030150208 |
50 |
17 |
510 |
0.56 |
0.04 |
0.99 |
|
6 |
2006 |
99 |
392 |
41 |
1130 |
70 |
69 |
70 |
27 |
14 |
46 |
119 |
65 |
189 |
146 |
89 |
218 |
3600 |
1800 |
6000 |
0.003946605554348407 |
0.002457320439499952 |
0.005733747692166554 |
49 |
17 |
460 |
0.58 |
0.04 |
0.99 |
|
7 |
2007 |
95 |
383 |
43 |
1080 |
68 |
68 |
69 |
29 |
15 |
48 |
116 |
63 |
185 |
145 |
89 |
215 |
3900 |
2000 |
6500 |
0.0038292116686338942 |
0.002384226133300349 |
0.005635443587800825 |
47 |
17 |
420 |
0.58 |
0.05 |
0.99 |
|
8 |
2008 |
97 |
371 |
47 |
1020 |
63 |
50 |
75 |
33 |
14 |
60 |
105 |
54 |
173 |
138 |
82 |
209 |
4600 |
2000 |
8300 |
0.003713764345816206 |
0.002312343837961034 |
0.005465539980635171 |
46 |
17 |
370 |
0.55 |
0.05 |
0.98 |
|
9 |
2009 |
95 |
356 |
50 |
952 |
64 |
64 |
65 |
32 |
16 |
53 |
106 |
58 |
170 |
138 |
85 |
204 |
4500 |
2300 |
7500 |
0.003533904620729803 |
0.002174710535833725 |
0.0052328972268499 |
45 |
17 |
310 |
0.56 |
0.06 |
0.98 |
|
10 |
2010 |
97 |
338 |
55 |
870 |
77 |
53 |
94 |
20 |
4.2 |
48 |
125 |
61 |
211 |
145 |
77 |
233 |
3000 |
620 |
7100 |
0.0032966101946351623 |
0.0019779661167810977 |
0.005010847495845447 |
42 |
16 |
260 |
0.6 |
0.04 |
1 |
|
11 |
2011 |
99 |
316 |
61 |
777 |
60 |
59 |
60 |
34 |
17 |
57 |
93 |
50 |
149 |
127 |
79 |
186 |
5100 |
2600 |
8600 |
0.003135474644952289 |
0.0017916997971155937 |
0.004799195885131054 |
40 |
16 |
210 |
0.54 |
0.07 |
0.96 |
|
12 |
2012 |
99 |
291 |
67 |
675 |
59 |
59 |
60 |
29 |
15 |
49 |
79 |
42 |
127 |
108 |
67 |
158 |
4600 |
2300 |
7600 |
0.0029197433980408523 |
0.001677299398874532 |
0.004597042796915384 |
45 |
19 |
190 |
47 |
0.48 |
0.09 |
0.89 |
13 |
2013 |
96 |
261 |
73 |
567 |
56 |
55 |
57 |
30 |
15 |
50 |
69 |
37 |
112 |
99 |
62 |
145 |
4700 |
2400 |
7900 |
0.002593932478248519 |
0.0013874522558073473 |
0.0042226807785441 |
42 |
20 |
150 |
44 |
0.47 |
0.11 |
0.86 |
14 |
2014 |
97 |
228 |
78 |
455 |
54 |
53 |
55 |
27 |
13 |
45 |
57 |
31 |
92 |
84 |
53 |
122 |
4400 |
2200 |
7400 |
0.002284865554409738 |
0.0012303122216052434 |
0.0036323503685488138 |
43 |
22 |
130 |
45 |
0.44 |
0.12 |
0.78 |
15 |
2015 |
90 |
197 |
81 |
364 |
53 |
52 |
54 |
22 |
11 |
37 |
46 |
25 |
74 |
68 |
43 |
99 |
3700 |
1900 |
6200 |
0.0019347194915648222 |
0.0010242632602402 |
0.003129693295178389 |
47 |
26 |
110 |
50 |
0.39 |
0.13 |
0.69 |
16 |
2016 |
86 |
176 |
81 |
307 |
53 |
52 |
53 |
19 |
9.5 |
31 |
38 |
20 |
61 |
57 |
36 |
82 |
3300 |
1700 |
5400 |
0.0016029560720943312 |
0.0008291152097039644 |
0.0025426199764254907 |
51 |
29 |
110 |
58 |
0.36 |
0.14 |
0.62 |
17 |
2017 |
89 |
162 |
80 |
272 |
49 |
49 |
50 |
16 |
8.3 |
27 |
29 |
16 |
47 |
46 |
29 |
65 |
2900 |
1500 |
4800 |
0.0012887909980526368 |
0.0006980951239451783 |
0.002094285371835535 |
57 |
34 |
120 |
71 |
0.31 |
0.13 |
0.52 |
18 |
2018 |
92 |
153 |
79 |
250 |
48 |
48 |
49 |
16 |
8.2 |
27 |
28 |
15 |
44 |
44 |
28 |
63 |
3000 |
1500 |
4900 |
56 |
34 |
110 |
0.31 |
0.13 |
0.52 |
||||
19 |
2019 |
146 |
78 |
235 |
47 |
46 |
47 |
14 |
7.3 |
23 |
23 |
12 |
36 |
37 |
24 |
53 |
2700 |
1400 |
4400 |
61 |
38 |
110 |
0.27 |
0.12 |
0.45 |
|||||
20 |
2020 |
138 |
73 |
225 |
45 |
44 |
45 |
16 |
7.9 |
26 |
24 |
13 |
38 |
40 |
26 |
57 |
3000 |
1500 |
5100 |
56 |
35 |
110 |
0.31 |
0.14 |
0.52 |
|||||
21 |
2021 |
132 |
67 |
218 |
45 |
44 |
46 |
15 |
7.3 |
26 |
24 |
13 |
39 |
39 |
25 |
57 |
3000 |
1500 |
5100 |
55 |
33 |
110 |
0.32 |
0.13 |
0.55 |
|||||
22 |
2022 |
125 |
61 |
212 |
48 |
48 |
49 |
9.5 |
4.6 |
16 |
18 |
9.4 |
28 |
27 |
17 |
39 |
1900 |
930 |
3300 |
71 |
42 |
150 |
0.24 |
0.1 |
0.42 |
|||||
23 |
2023 |
|||||||||||||||||||||||||||||
24 |
2024 |
|||||||||||||||||||||||||||||
25 |
2025 |
|||||||||||||||||||||||||||||
26 |
2026 |
|||||||||||||||||||||||||||||
27 |
2027 |
|||||||||||||||||||||||||||||
28 |
2028 |
|||||||||||||||||||||||||||||
29 |
2029 |
|||||||||||||||||||||||||||||
30 |
2030 |
|||||||||||||||||||||||||||||
31 |
2031 |
|||||||||||||||||||||||||||||
32 |
2032 |
|||||||||||||||||||||||||||||
33 |
2033 |
|||||||||||||||||||||||||||||
34 |
2034 |
|||||||||||||||||||||||||||||
35 |
2035 |
|||||||||||||||||||||||||||||
36 |
2036 |
|||||||||||||||||||||||||||||
37 |
2037 |
|||||||||||||||||||||||||||||
38 |
2038 |
|||||||||||||||||||||||||||||
39 |
2039 |
|||||||||||||||||||||||||||||
40 |
2040 |
|||||||||||||||||||||||||||||
41 |
2041 |
|||||||||||||||||||||||||||||
42 |
2042 |
|||||||||||||||||||||||||||||
43 |
2043 |
|||||||||||||||||||||||||||||
44 |
2044 |
|||||||||||||||||||||||||||||
45 |
2045 |
|||||||||||||||||||||||||||||
46 |
2046 |
|||||||||||||||||||||||||||||
47 |
2047 |
|||||||||||||||||||||||||||||
48 |
2048 |
|||||||||||||||||||||||||||||
49 |
2049 |
|||||||||||||||||||||||||||||
50 |
2050 |
WHO_latentTB2017
variable |
definition |
value |
|
---|---|---|---|
0 |
year |
2017 |
|
1 |
source_hh |
Source of estimate of average household size |
DHS 2015 |
2 |
e_hh_size |
Estimated average household size |
4.508918 |
3 |
prevtx_data_available |
Are data available on the number of children aged under 5 who are household contacts of TB cases and started on TB preventive therapy? |
60 |
4 |
newinc_con04_prevtx |
Number of children aged under 5 started on TB preventive therapy who are household contacts of bacteriologically-confirmed new and relapse TB cases notified |
3068 |
5 |
ptsurvey_newinc |
Number of bacteriologically-confirmed TB new and relapse cases notified in the reporting year whose medical records or treatment cards were included in a survey |
|
6 |
ptsurvey_newinc_con04_prevtx |
Number of children aged under 5 started on TB preventive therapy who are household contacts of the TB cases in ptsurvey_newinc |
|
7 |
e_prevtx_eligible |
Estimated number of children aged under 5 who are household contacts of TB cases who are eligible for TB preventive therapy |
4400 |
8 |
e_prevtx_eligible_hi |
Estimated number of children aged under 5 who are household contacts of TB cases who are eligible for TB preventive therapy: high bound |
4000 |
9 |
e_prevtx_eligible_lo |
Estimated number of children aged under 5 who are household contacts of TB cases who are eligible for TB preventive therapy: low bound |
4800 |
10 |
e_prevtx_kids_pct |
Estimated % of children received TB preventive therapy aged under 5 who are household contacts of TB cases and who are eligible for TB preventive therapy |
69 |
11 |
e_prevtx_kids_pct_hi |
Estimated % of children received TB preventive therapy aged under 5 who are household contacts of TB cases and who are eligible for TB preventive therapy: High bound |
64 |
12 |
e_prevtx_kids_pct_lo |
Estimated % of children received TB preventive therapy aged under 5 who are household contacts of TB cases and who are eligible for TB preventive therapy: Low bound |
76 |
WHO_mdrTB2017
variable |
definition |
value |
|
---|---|---|---|
0 |
year |
2017 |
|
1 |
source_rr_new |
Method used to estimate proportion of new TB patients with rifampicin-resistant TB |
Survey |
2 |
source_drs_coverage_new |
Indicates whether national or subnational data from drug resistance surveys or surveillance was used to estimate the proportion of new TB cases with MDR-TB |
National |
3 |
source_drs_year_new |
Year of drug resistance surveillance, survey or model used to estimate proportion of new TB cases with MDR-TB |
2011 |
4 |
e_rr_pct_new |
Estimated percentage of new TB cases with rifampicin resistant TB |
0.75 |
5 |
e_rr_pct_new_hi |
Estimated percentage of new TB cases with rifampicin resistant TB: high bound |
0.16 |
6 |
e_rr_pct_new_lo |
Estimated percentage of new TB cases with rifampicin resistant TB: low bound |
1.8 |
7 |
e_mdr_pct_rr_new |
Estimated percentage of new rifampicin resistant TB cases that have MDR-TB |
56 |
8 |
source_rr_ret |
Method used to estimate proportion of previously treated TB patients with rifampicin-resistant TB |
Survey |
9 |
source_drs_coverage_ret |
Indicates whether national or subnational data from drug resistance surveys or surveillance was used to estimate the proportion of previously treated TB cases with MDR-TB |
National |
10 |
source_drs_year_ret |
Year of drug resistance surveillance, survey or model used to estimate proportion of previously treated TB cases with MDR-TB |
2011 |
11 |
e_rr_pct_ret |
Estimated percentage of previously treated TB cases with rifampicin resistant TB |
6.4 |
12 |
e_rr_pct_ret_hi |
Estimated percentage of previously treated TB cases with rifampicin resistant TB: high bound |
4 |
13 |
e_rr_pct_ret_lo |
Estimated percentage of previously treated TB cases with rifampicin resistant TB: low bound |
9.2 |
14 |
e_mdr_pct_rr_ret |
Estimated percentage of previously treated rifampicin resistant TB cases that have MDR-TB |
76 |
15 |
e_inc_rr_num |
Estimated incidence of rifampicin resistant TB (absolute number) |
330 |
16 |
e_inc_rr_num_hi |
Estimated incidence of rifampicin resistant TB (absolute number): high bound |
90 |
17 |
e_inc_rr_num_lo |
Estimated incidence of rifampicin resistant TB (absolute number): low bound |
710 |
18 |
e_mdr_pct_rr |
Estimated percentage of rifampicin resistant TB cases that have MDR-TB |
63 |
19 |
e_rr_in_notified_pulm |
Estimated number of RR-TB cases among notified pulmonary TB cases |
180 |
20 |
e_rr_in_notified_pulm_hi |
Estimated number of RR-TB cases among notified pulmonary TB cases: high bound |
83 |
21 |
e_rr_in_notified_pulm_lo |
Estimated number of RR-TB cases among notified pulmonary TB cases: low bound |
270 |
WHO_tx_success_rates2021
year |
Are outcomes of relapse cases included in the newrel outcome variables? |
Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): cohort size |
Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): treatment success (cured or treatment completed) |
Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): treatment failed |
Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): died |
Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): lost to follow-up |
Treatment success rate for all new cases (including relapse cases if rel_with_new_flg = 1), percent |
Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): cohort size |
Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): treatment success (cured or treatment completed) |
Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): treatment failed |
Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): died |
Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): lost to follow-up |
Treatment success rate for re-treatment cases (excluding relapse cases if rel_with_new_flg = 1), percent |
Outcomes for HIV-positive TB cases, all types: cohort size |
Outcomes for HIV-positive TB cases, all types: treatment success (cured or treatment completed) |
Outcomes for HIV-positive TB cases, all types: treatment failed |
Outcomes for HIV-positive TB cases, all types: died |
Outcomes for HIV-positive TB cases, all types: lost to follow-up |
Treatment success rate for HIV-positive TB cases, percent |
Outcomes for new and relapse cases in children aged 0-14 years: cohort size |
Outcomes for new and relapse cases in children aged 0-14 years: treatment success |
Outcomes for new and relapse cases in children aged 0-14 years: treatment failed |
Outcomes for new and relapse cases in children aged 0-14 years: died |
Outcomes for new and relapse cases in children aged 0-14 years: lost to follow-up |
Treatment success rate for new and relapse cases in children aged 0-14 years, percent |
Outcomes for MDR-TB cases: cohort size |
Outcomes for MDR-TB cases: treatment success (Cured or treatment completed) |
Outcomes for MDR-TB cases: treatment failed |
Outcomes for MDR-TB cases: died |
Outcomes for MDR-TB cases: lost to follow-up |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 |
2010 |
83 |
77 |
26 |
18 |
2 |
5 |
1 |
|||||||||||||||||||||||
1 |
2011 |
83 |
82 |
16 |
11 |
4 |
1 |
||||||||||||||||||||||||
2 |
2012 |
1 |
19361 |
15849 |
159 |
2015 |
292 |
82 |
1493 |
847 |
8 |
136 |
8 |
57 |
19 |
12 |
0 |
6 |
1 |
||||||||||||
3 |
2013 |
1 |
17779 |
14506 |
139 |
1710 |
312 |
82 |
19 |
10 |
0 |
7 |
1 |
||||||||||||||||||
4 |
2014 |
1 |
16267 |
13867 |
148 |
1414 |
332 |
85 |
1456 |
1086 |
8 |
152 |
30 |
75 |
53 |
31 |
0 |
18 |
2 |
||||||||||||
5 |
2015 |
1 |
15597 |
12585 |
164 |
1576 |
358 |
81 |
1284 |
977 |
9 |
218 |
32 |
76 |
7799 |
6320 |
92 |
959 |
108 |
81 |
64 |
39 |
0 |
21 |
3 |
||||||
6 |
2016 |
1 |
15683 |
12877 |
153 |
1590 |
311 |
82 |
1023 |
828 |
11 |
130 |
14 |
81 |
7804 |
6244 |
101 |
938 |
121 |
80 |
58 |
34 |
1 |
17 |
5 |
||||||
7 |
2017 |
1 |
16321 |
14003 |
104 |
1586 |
266 |
86 |
352 |
281 |
9 |
37 |
11 |
80 |
7763 |
6498 |
67 |
938 |
117 |
84 |
58 |
32 |
1 |
20 |
4 |
||||||
8 |
2018 |
1 |
15435 |
13522 |
140 |
1286 |
246 |
88 |
321 |
259 |
13 |
21 |
19 |
81 |
7268 |
6222 |
81 |
790 |
73 |
86 |
1183 |
1096 |
93 |
NTP2019
year |
case_notification_rate_per_100k |
treatment_coverage |
treatment_success_rates |
death_rate |
percent_hiv_positive |
number_notified_mdr_cases |
percent_mdr_treatment_success |
percent_death_mdr_cases |
coverage_ipt_paediatric_contacts |
|
---|---|---|---|---|---|---|---|---|---|---|
0 |
2010 |
|||||||||
1 |
2011 |
46 |
82.7 |
10.7 |
||||||
2 |
2012 |
138 |
51 |
81.8 |
10.7 |
27 |
63.2 |
31.6 |
||
3 |
2013 |
126 |
48 |
83.3 |
9.8 |
91 |
52.6 |
36.8 |
||
4 |
2014 |
112 |
46 |
85 |
8.9 |
106 |
58.6 |
34 |
35 |
|
5 |
2015 |
105 |
46 |
81.6 |
10.6 |
42.6 |
107 |
60.9 |
32.8 |
42 |
6 |
2016 |
101 |
47 |
82.1 |
10.3 |
38.8 |
66 |
58.6 |
29.3 |
51 |
7 |
2017 |
95 |
50 |
86 |
9.7 |
39.1 |
85 |
55 |
35 |
61 |
8 |
2018 |
88 |
48 |
87.2 |
8.6 |
38.5 |
126 |
68.8 |
17 |
57 |
9 |
2019 |
92 |
51 |
87.6 |
8.2 |
35.5 |
104 |
73 |
16 |
57 |
10 |
2020 |
76 |
56 |
89 |
8 |
45 |
97 |
76 |
48 |
|
11 |
2021 |
41 |